open access

Vol 26, No 3 (2019)
Original articles — Clinical cardiology
Submitted: 2017-11-13
Accepted: 2017-12-14
Published online: 2017-12-28
Get Citation

OCULUS study: Virtual reality-based education in daily clinical practice

Paweł Balsam1, Sonia Borodzicz1, Karolina Malesa1, Dominika Puchta1, Agata Tymińska1, Krzysztof Ozierański1, Łukasz Kołtowski1, Michał Peller1, Marcin Grabowski1, Krzysztof J. Filipiak1, Grzegorz Opolski1
·
Pubmed: 29297178
·
Cardiol J 2019;26(3):260-264.
Affiliations
  1. First Chair and Department of Cardiology, Medical University of Warsaw, Poland

open access

Vol 26, No 3 (2019)
Original articles — Clinical cardiology
Submitted: 2017-11-13
Accepted: 2017-12-14
Published online: 2017-12-28

Abstract

Background: Atrial fibrillation (AF) is associated with high risk of stroke and other thromboembolic complications. The OCULUS study aimed to evaluate the effectiveness of the three-dimensional (3D) movie in teaching patients about the consequences of AF and pharmacological stroke prevention. 

Methods: The study was based on a questionnaire and included 100 consecutive patients (38% women, 62% with AF history). Using the oculus glasses and a smartphone, a 3D movie describing the risk of stroke in AF was shown. Similar questions were asked immediately after, 1 week and 1 year after the projection. 

Results: Before the projection 22/100 (22.0%) declared stroke a consequence of AF, while immediately after 83/100 (83.0%) (p < 0.0001) patients declared this consequence. Seven days after, stroke as AF consequence was chosen by 74/94 (78.7%) vs. 22/94 (23.4%) when compared to the baseline knowledge; p < 0.0001, a similar trend was also observed in 1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; p < 0.0001). Before the projection 88.3% (83/94) patients responded, that drugs may reduce the risk of stroke, and after 1 week the number of patients increased to (94/94 [100%]; p = 0.001). After 1 year 87/90 (96.7%) answered that drugs may diminish the risk of stroke (p = 0.02 in comparison to the baseline survey 78/90 [86.7%]). Use of oral anticoagulation to reduce the risk of stroke was initially chosen by 66/94 (70.2%), by 90/94 (95.7%; p < 0.0001) 7 days after and by 83/90 (92.2%; p < 0.0001) 1 year after. 

Conclusions: 3D movie is an effective tool in transferring knowledge about the consequences of AF and the pivotal role of oral anticoagulation in stroke prevention.

Trial registration: ClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.

Abstract

Background: Atrial fibrillation (AF) is associated with high risk of stroke and other thromboembolic complications. The OCULUS study aimed to evaluate the effectiveness of the three-dimensional (3D) movie in teaching patients about the consequences of AF and pharmacological stroke prevention. 

Methods: The study was based on a questionnaire and included 100 consecutive patients (38% women, 62% with AF history). Using the oculus glasses and a smartphone, a 3D movie describing the risk of stroke in AF was shown. Similar questions were asked immediately after, 1 week and 1 year after the projection. 

Results: Before the projection 22/100 (22.0%) declared stroke a consequence of AF, while immediately after 83/100 (83.0%) (p < 0.0001) patients declared this consequence. Seven days after, stroke as AF consequence was chosen by 74/94 (78.7%) vs. 22/94 (23.4%) when compared to the baseline knowledge; p < 0.0001, a similar trend was also observed in 1-year follow-up (64/90 [71.1%] vs. 21/90 [23.3%]; p < 0.0001). Before the projection 88.3% (83/94) patients responded, that drugs may reduce the risk of stroke, and after 1 week the number of patients increased to (94/94 [100%]; p = 0.001). After 1 year 87/90 (96.7%) answered that drugs may diminish the risk of stroke (p = 0.02 in comparison to the baseline survey 78/90 [86.7%]). Use of oral anticoagulation to reduce the risk of stroke was initially chosen by 66/94 (70.2%), by 90/94 (95.7%; p < 0.0001) 7 days after and by 83/90 (92.2%; p < 0.0001) 1 year after. 

Conclusions: 3D movie is an effective tool in transferring knowledge about the consequences of AF and the pivotal role of oral anticoagulation in stroke prevention.

Trial registration: ClinicalTrials.gov, NCT03104231. Registered on 28 March 2017.

Get Citation

Keywords

atrial fibrillation; stroke; education; virtual reality; three-dimensional movie

Supp./Additional Files (1)
Supplementary material - questionnaire
Download
18KB
About this article
Title

OCULUS study: Virtual reality-based education in daily clinical practice

Journal

Cardiology Journal

Issue

Vol 26, No 3 (2019)

Pages

260-264

Published online

2017-12-28

Page views

4159

Article views/downloads

2688

DOI

10.5603/CJ.a2017.0154

Pubmed

29297178

Bibliographic record

Cardiol J 2019;26(3):260-264.

Keywords

atrial fibrillation
stroke
education
virtual reality
three-dimensional movie

Authors

Paweł Balsam
Sonia Borodzicz
Karolina Malesa
Dominika Puchta
Agata Tymińska
Krzysztof Ozierański
Łukasz Kołtowski
Michał Peller
Marcin Grabowski
Krzysztof J. Filipiak
Grzegorz Opolski

References (13)
  1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Rev Esp Cardiol. 2017; 70(1): 50.
  2. Hernández Madrid A, Potpara TS, Dagres N, et al. Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European Heart Rhythm Association. Europace. 2016; 18(3): 463–467.
  3. Milewski K, Małecki A, Orszulik-Baron D, et al. The use of modern telemedicine technologies in an innovative optimal cardiac rehabilitation program for patients after myocardial revascularization: Concept and design of RESTORE, a randomized clinical trial. Cardiol J. 2018 [Epub ahead of print].
  4. Rymuza B, Grodecki K, Kamiński J, et al. Wykorzystanie hologramu podczas przezcewnikowego wszczepienia zastawki aortalnej u pacjenta ze stenozą dwupłatkowej zastawki aortalnej. Kardiol Pol. 2017; 75(10): 1056–1056.
  5. Olejník P, Nosal M, Havran T, et al. Utilisation of three-dimensional printed heart models for operative planning of complex congenital heart defects. Kardiol Pol. 2017; 75(5): 495–501.
  6. Pison L, Potpara TS, Chen J, et al. Scientific Initiative Committee, European Heart Rhythm Association, Scientific Initiatives Committee, and European Heart Rhythm Association. How are patients with atrial fibrillation approached and informed about their risk profile and available therapies in Europe? Results of the European Heart Rhythm Association Survey. Europace. 2015; 17(3): 468–472.
  7. Amara W, Larsen TB, Sciaraffia E, et al. Patients' attitude and knowledge about oral anticoagulation therapy: results of a self-assessment survey in patients with atrial fibrillation conducted by the European Heart Rhythm Association. Europace. 2016; 18(1): 151–155.
  8. Cleeren G, Quirynen M, Ozcelik O, et al. Role of 3D animation in periodontal patient education: a randomized controlled trial. J Clin Periodontol. 2014; 41(1): 38–45.
  9. Zygouris S, Ntovas K, Giakoumis D, et al. A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment. J Alzheimers Dis. 2017; 56(2): 619–627.
  10. Schmid L, Glässel A, Schuster-Amft C. Therapists' Perspective on Virtual Reality Training in Patients after Stroke: A Qualitative Study Reporting Focus Group Results from Three Hospitals. Stroke Res Treat. 2016; 2016: 6210508.
  11. Ravi DK, Kumar N, Singhi P. Effectiveness of virtual reality rehabilitation for children and adolescents with cerebral palsy: an updated evidence-based systematic review. Physiotherapy. 2017; 103(3): 245–258.
  12. Li A, Montaño Z, Chen VJ, et al. Virtual reality and pain management: current trends and future directions. Pain Manag. 2011; 1(2): 147–157.
  13. Moshtaghi O, Haidar YM, Sahyouni R, et al. Use of interactive iBooks for patient education in otology. Am J Otolaryngol. 2017; 38(2): 174–178.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl